ISTH-0036 | m-entrepreneurship.com

Product Name :
ISTH-0036

Search keywords :
ISTH0036

drugId :
null

Target Vo:
Transforming growth factor beta 2

Target Vo Short Name :
TGF-β2

Moa_Name:
Transforming growth factor beta 2 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Isarna Therapeutics Gmbh

Active Company_Name :
Isarna Therapeutics Gmbh

Active Indication_Name:
Wet Macular Degeneration

In Active Indication_Name:
Glaucoma, Open-Angle

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-p53 (Ser6) Antibody
DRP1 Antibody
CD11c Antibody: CD11c Antibody is an unconjugated, approximately 126 kDa, rabbit-derived, anti-CD11c polyclonal antibody. CD11c Antibody can be used for: ELISA, Flow-Cyt, IF expriments in human, rat, and predicted: mouse, dog background without labeling.

Author: Betaine hydrochloride

Related Posts